253 assets in Diffuse Large B-Cell Lymphoma

Vincristine Sulfate

Melphalan

Axicabtagene Ciloleucel

Adriamycin

Cyclosporin A

Nivestim

Prednisone

Cyclophosphamide

Dexasone

Rituximab

(+)-Vincristine

Etoposide

Pegfilgrastim

Selinexor

Busulfanum

Capecitabine

Golcadomide

Cytarabine

Polatuzumab Vedotin

Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)

Isocyclophosphamide

Lenalidomide

Camustine

Cis-Diamminedichloroplatinum Ii

Epirubicin

Romidepsin

Tislelizumab

Zanubrutinib

Bendamustine

Decitabine

Jcar-017 Cd19-Specific Chimeric Antigen Receptor

Lomustine

Mesna

Oxaliplatin

Pembrolizumab

Venetoclax

Vindesine

Vorinostat

Acalabrutinib

Carboplatin

Daratumumab

Epcoritamab

Fludarabine

Tucidinostat

Methotrexate

Nivolumab

Obinutuzumab

Prednisolone

Zilovertamab Vedotin

Brentuximab Vedotin